Excessive inflammatory response of cystic fibrosis mice to bronchopulmonary infection with Pseudomonas aeruginosa

被引:220
作者
van Heeckeren, A [1 ]
Walenga, R [1 ]
Konstan, MW [1 ]
Bonfield, T [1 ]
Davis, PB [1 ]
Ferkol, T [1 ]
机构
[1] Case Western Reserve Univ, Rainbow Babies & Childrens Hosp, Sch Med, Div Pediat Pulmonol,Dept Pediat, Cleveland, OH 44106 USA
关键词
Pseudomonas aeruginosa; lung; cystic fibrosis; inflammation;
D O I
10.1172/JCI119828
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
In cystic fibrosis (CF), defective function of the cystic fibrosis transmembrane conductance regulator (CFTR) in airway epithelial cells and submucosal glands results in chronic pulmonary infection with Pseudomonas aeruginosa. The pulmonary infection incites an intense host inflammatory response, causing progressive suppurative pulmonary disease, Mouse models of CF, however, fail to develop pulmonary disease spontaneously, We examined the effects of bronchopulmonary infection on mice homozygous for the S489X mutation of the CFTR gene using an animal model of chronic Pseudomonas endobronchial infection, Slurries of sterile agarose beads or beads containing a clinical isolate of mucoid P. aeruginosa were instilled in the right lung of normal or CF mice, The mortality of CF mice inoculated with Pseudomonas-laden beads was significantly higher than that of normal animals: 82% of infected CF mice, but only 23% of normal mice, died within 10 d of infection (P = 0.023), The concentration of inflammatory mediators, including TNF-alpha, murine macrophage inflammatory protein-2, and KC/N51, in bronchoalveolar lavage fluid in CF mice 3 d after infection and before any mortality, was markedly elevated compared with normal mice, This inflammatory response also correlated with weight loss observed in both CF and normal littermates after inoculation, Thus, this model may permit, examination of the relationship of bacterial infections, inflammation, and the cellular and genetic defects in CF.
引用
收藏
页码:2810 / 2815
页数:6
相关论文
共 50 条
  • [21] Evaluating the "Leeds criteria'' for Pseudomonas aeruginosa infection in a cystic fibrosis centre
    Proesmans, M
    Balinska-Miskiewicz, W
    Dupont, L
    Bossuyt, X
    Verhaegen, J
    Hoiby, N
    de Boeck, K
    EUROPEAN RESPIRATORY JOURNAL, 2006, 27 (05) : 937 - 943
  • [22] Epidemiology of Clonal Pseudomonas aeruginosa Infection in a Canadian Cystic Fibrosis Population
    Middleton, Maggie A.
    Layeghifard, Mehdi
    Klingel, Michelle
    Stanojevic, Sanja
    Yau, Yvonne C. W.
    Zlosnik, James E. A.
    Coriati, Adele
    Ratjen, Felix A.
    Tullis, Elizabeth D.
    Stephenson, Anne
    Wilcox, Pearce
    Freitag, Andreas
    Chilvers, Mark
    McKinney, Martha
    Lavoie, Annick
    Wang, Pauline W.
    Guttman, David S.
    Waters, Valerie J.
    ANNALS OF THE AMERICAN THORACIC SOCIETY, 2018, 15 (07) : 827 - 836
  • [23] Pseudomonas aeruginosa in cystic fibrosis:: cross-infection and the need for segregation
    Tubbs, D
    Lenney, W
    Alcock, P
    Campbell, CA
    Gray, J
    Pantin, C
    RESPIRATORY MEDICINE, 2001, 95 (02) : 147 - 152
  • [24] Why is Pseudomonas aeruginosa a common cause of infection in individuals with cystic fibrosis?
    Gross, Jeremy
    Welch, Martin
    FUTURE MICROBIOLOGY, 2013, 8 (06) : 697 - 699
  • [25] Impact of CFTR Modulation on Pseudomonas aeruginosa Infection in People With Cystic Fibrosis
    Ledger, Emma L.
    Smith, Daniel J.
    Teh, Jing Jie
    Wood, Michelle E.
    Whibley, Page E.
    Morrison, Mark
    Goldberg, Joanna B.
    Reid, David W.
    Wells, Timothy J.
    JOURNAL OF INFECTIOUS DISEASES, 2024, 230 (03) : e536 - e547
  • [26] Pseudomonas aeruginosa biofilms in cystic fibrosis
    Hoiby, Niels
    Ciofu, Oana
    Bjarnsholt, Thomas
    FUTURE MICROBIOLOGY, 2010, 5 (11) : 1663 - 1674
  • [27] Mouse models of chronic lung infection with Pseudomonas aeruginosa:: Models for the study of cystic fibrosis
    Stotland, PK
    Radzioch, D
    Stevenson, MM
    PEDIATRIC PULMONOLOGY, 2000, 30 (05) : 413 - 424
  • [28] Mucociliary clearance in cystic fibrosis knockout mice infected with Pseudomonas aeruginosa
    Cowley, EA
    Wang, CG
    Gosselin, D
    Radzioch, D
    Eidelman, DH
    EUROPEAN RESPIRATORY JOURNAL, 1997, 10 (10) : 2312 - 2318
  • [29] Prophylaxis and therapy of Pseudomonas aeruginosa infection in cystic fibrosis and immunocompromised patients
    Lang, AB
    Horn, MP
    Imboden, MA
    Zuercher, AW
    VACCINE, 2004, 22 : S44 - S48
  • [30] Study of IgG antibodies to Pseudomonas aeruginosa in early cystic fibrosis infection
    Giordano, A
    Magni, A
    Filadoro, F
    Graziani, C
    Quattrucci, S
    Cipriani, P
    MICROBIOLOGICA, 1998, 21 (04): : 375 - 378